Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Functional impact of HIV coreceptor-binding site mutations.

Biscone MJ, Miamidian JL, Muchiri JM, Baik SS, Lee FH, Doms RW, Reeves JD.

Virology. 2006 Jul 20;351(1):226-36. Epub 2006 Apr 21.

2.

Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8.

Haskell CA, Horuk R, Liang M, Rosser M, Dunning L, Islam I, Kremer L, GutiƩrrez J, Marquez G, Martinez-A C, Biscone MJ, Doms RW, Ribeiro S.

Mol Pharmacol. 2006 Jan;69(1):309-16. Epub 2005 Oct 12.

PMID:
16221874
3.

Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.

Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P.

J Virol. 2004 Dec;78(24):13430-9.

4.

Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity.

Reeves JD, Miamidian JL, Biscone MJ, Lee FH, Ahmad N, Pierson TC, Doms RW.

J Virol. 2004 May;78(10):5476-85.

5.

Opportunities and challenges in targeting HIV entry.

Biscone MJ, Pierson TC, Doms RW.

Curr Opin Pharmacol. 2002 Oct;2(5):529-33. Review.

PMID:
12324254

Supplemental Content

Loading ...
Support Center